Combinatorial control of ATF4-dependent gene transcription in osteoblasts

Annals of the New York Academy of Sciences

Volumn 1237, Issue 1, 2011, Pages 11-18

  St Arnaud, René ^a,b   Hekmatnejad, Bahareh ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

ATF4; FIAT; Osteoblast; Transcription; NAC

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; POLYPEPTIDE; TRANSCRIPTION FACTOR IIA; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; COMBINATORIAL LIBRARY; DIMERIZATION; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; OSTEOBLAST; PROTEIN PROTEIN INTERACTION;

EID: 81255211176     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06197.x     Document Type: Article

References (61)

1. Briggs, M.R., J.T. Kadonaga, S.P. Bell, et al 1986. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science 234: 47-52.
2. Kadonaga, J.T., K.R. Carner, F.R. Masiarz, et al 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51: 1079-1090.
3. Kumar, R., R.A. Wang & C.J. Barnes 2004. Coregulators and chromatin remodeling in transcriptional control. Mol. Carcinog. 41: 221-230.
4. Pfahl, M. 1993. Nuclear receptor/AP-1 interaction. Endocr. Rev. 14: 651-658.
5. Jonat, C., H.J. Rahmsdorf, K.K. Park, et al 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189-1204.
6. Yang-Yen, H.F., J.C. Chambard, Y.L. Sun, et al 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215.
7. Schule, R., P. Rangarajan, S. Kliewer, et al 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62: 1217-1226.
8. Molkentin, J.D., B.L. Black, J.F. Martin, et al 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83: 1125-1136.
9. Hassan, M.Q., S. Saini, J.A. Gordon, et al 2009. Molecular switches involving homeodomain proteins, HOXA10 and RUNX2 regulate osteoblastogenesis. Cells Tissues Organs 189: 122-125.
10. Javed, A., F. Afzal, J.S. Bae, et al 2009. Specific residues of RUNX2 are obligatory for formation of BMP2-induced RUNX2-SMAD complex to promote osteoblast differentiation. Cells Tissues Organs 189: 133-137.
11. Franceschi, R.T., C. Ge, G. Xiao, et al 2009. Transcriptional regulation of osteoblasts. Cells Tissues Organs 189: 144-152.
12. Hai, T. & M.G. Hartman 2001. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273: 1-11.
13. Lassot, I., E. Segeral, C. Berlioz-Torrent, et al 2001. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase. Mol. Cell Biol. 21: 2192-2202.
14. Yang, X. & G. Karsenty 2004. ATF4, the osteoblast accumulation of which is determined post-translationally, can induce osteoblast-specific gene expression in non-osteoblastic cells. J. Biol. Chem. 279: 47109-47114.
15. Yang, X., K. Matsuda, P. Bialek, et al 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117: 387-398.
16. Elefteriou, F., J.D. Ahn, S. Takeda, et al 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520.
17. Yoshizawa, T., E. Hinoi, D.Y. Jung, et al 2009. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119: 2807-2817.
18. Harding, H.P., Y. Zhang, H. Zeng, et al 2003. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11: 619-633.
19. Landschulz, W.H., P.F. Johnson & S.L. McKnight 1988. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759-1764.
20. Gentz, R., F.J. Rauscher, 3rd, C. Abate, et al 1989. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243: 1695-1699.
21. Glover, J.N. & S.C. Harrison 1995. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373: 257-261.
22. Vallejo, M., D. Ron, C.P. Miller, et al 1993. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. USA 90: 4679-4683.
23. Hai, T. & T. Curran 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88: 3720-3724.
24. Chevray, P.M. & D. Nathans 1992. Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun. Proc. Natl. Acad. Sci. USA 89: 5789-5793.
25. Lin, K.L., C.H. Chou, S.C. Hsieh, et al 2010. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J. Bone Miner. Res. 25: 2489-2503.
26. Tominaga, H., S. Maeda, M. Hayashi, et al 2008. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol. Biol. Cell. 19: 5373-5386.
27. Xiao, G., D. Jiang, C. Ge, et al 2005. Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression. J. Biol. Chem. 280: 30689-30696.
28. Yu, S., Y. Jiang, D.L. Galson, et al 2008. General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2. J. Biol. Chem. 283: 5542-5553.
29. Hatta, M., Y. Yoshimura, Y. Deyama, et al 2006. Molecular characterization of the zinc finger transcription factor, Osterix. Int. J. Mol. Med. 17: 425-430.
30. MacDonald, P.N., D.R. Sherman, D.R. Dowd, et al 1995. The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem. 270: 4748-4752.
31. Zaidi, S.K., D.W. Young, A. Javed, et al 2007. Nuclear microenvironments in biological control and cancer. Nat. Rev. Cancer 7: 454-463.
32. Zaidi, S.K., A. Javed, J. Pratap, et al 2006. Alterations in intranuclear localization of Runx2 affect biological activity. J. Cell. Physiol. 209: 935-942.
33. Bode, J., C. Benham, A. Knopp, et al 2000. Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit. Rev. Eukaryot. Gene Expr. 10: 73-90.
34. Dobreva, G., J. Dambacher & R. Grosschedl 2003. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev. 17: 3048-3061.
35. Dobreva, G., M. Chahrour, M. Dautzenberg, et al 2006. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125: 971-986.
36. Rached, M.T., A. Kode, L. Xu, et al 2010. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 11: 147-160.
37. Salih, D.A. & A. Brunet 2008. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 20: 126-136.
38. Sedding, D.G. 2008. FoxO transcription factors in oxidative stress response and ageing-a new fork on the way to longevity? Biol. Chem. 389: 279-283.
39. Elefteriou, F., M.D. Benson, H. Sowa, et al 2006. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab. 4: 441-451.
40. Sowa, H. & G. Karsenty 2007. ATF4 is a key molecule linking food intake and skeletal development. J. Musculoskelet Neuronal Interact. 7: 326-327.
41. Majeska, R.J., S.B. Rodan & G.A. Rodan 1980. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107: 1494-1503.
42. Lian, N., W. Wang, L. Li, et al 2009. Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation. J. Biol. Chem. 284: 30518-30525.
43. Chandhoke, T.K., Y.F. Huang, F. Liu, et al 2008. Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor. Bone 43: 101-109.
44. Molina, C.A., N.S. Foulkes, E. Lalli, et al 1993. Inducibility and negative autoregulation of CREM: an alternative promoter directs the expression of ICER, an early response repressor. Cell 75: 875-886.
45. Tetradis, S., J.M. Nervina, K. Nemoto, et al 1998. Parathyroid hormone induces expression of the inducible cAMP early repressor in osteoblastic MC3T3-E1 cells and mouse calvariae. J. Bone Miner. Res. 13: 1846-1851.
46. Nervina, J.M., S. Tetradis, Y.F. Huang, et al 2003. Expression of inducible cAMP early repressor is coupled to the cAMP-protein kinase A signaling pathway in osteoblasts. Bone 32: 483-490.
47. Nogami, S., S. Satoh, S. Tanaka-Nakadate, et al 2004. Identification and characterization of taxilin isoforms. Biochem. Biophys. Res. Commun. 319: 936-943.
48. Yu, V.W., G. Ambartsoumian, L. Verlinden, et al 2005. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice. J. Cell Biol. 169: 591-601.
49. Yu, V.W., C. Gauthier & R. St-Arnaud 2008. FIAT represses bone matrix mineralization by interacting with ATF4 through its second leucine zipper. J. Cell. Biochem. 105: 859-865.
50. Yu, V.W., J. El-Hoss & R. St-Arnaud 2009. FIAT inhibition increases osteoblast activity by modulating Atf4-dependent functions. J. Cell. Biochem. 106: 186-192.
51. Yu, V.W., C. Gauthier & R. St-Arnaud 2006. Inhibition of ATF4 transcriptional activity by FIAT/gamma-taxilin modulates bone mass accrual. Ann. N. Y. Acad. Sci. 1068: 131-142.
52. Yoshida, K., S. Nogami, S. Satoh, et al 2005. Interaction of the taxilin family with the nascent polypeptide-associated complex that is involved in the transcriptional and translational processes. Genes Cells 10: 465-476.
53. Akhouayri, O., I. Quelo & R. St-Arnaud 2005. Sequence-specific DNA binding by the {alpha}NAC coactivator is required for potentiation of c-Jun-dependent transcription of theOsteocalcingene. Mol. Cell Biol. 25: 3452-3460.
54. Meury, T., O. Akhouayri, T. Jafarov, et al 2010. Nuclear alpha NAC influences bone matrix mineralization and osteoblast maturation in vivo. Mol. Cell Biol. 30: 43-53.
55. Moreau, A., W.V. Yotov, F.H. Glorieux, et al 1998. Bone-specific expression of the alpha chain of the nascent polypeptide- associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol. Cell Biol. 18: 1312-1321.
56. Quelo, I., O. Akhouayri, J. Prud'homme, et al 2004. GSK3beta-dependent phosphorylation of the alphaNAC coactivator regulates its nuclear translocation and proteasome-mediated degradation. Biochemistry 43: 2906-2914.
57. Quelo, I., C. Gauthier, G. E. Hannigan, et al 2004. Integrin-linked kinase regulates the nuclear entry of the c-Jun coactivator alpha-NAC and its coactivation potency. J. Biol. Chem. 279: 43893-43899.
58. Quelo, I., C. Gauthier & R. St-Arnaud 2005. Casein kinase II phosphorylation regulates alphaNAC subcellular localization and transcriptional coactivating activity. Gene Expr. 12: 151-163.
59. Quelo, I., M. Hurtubise & R. St-Arnaud 2002. alphaNAC requires an interaction with c-Jun to exert its transcriptional coactivation. Gene Expr. 10: 255-262.
60. Yotov, W.V. & R. St-Arnaud 1996. Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor. Genes Dev. 10: 1763-1772.
61. Bakiri, L., K. Matsuo, M. Wisniewska, et al 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell Biol. 22: 4952-4964.